Molecular pathways documented in preclinical research include: (1) activation of nitric oxide (NO) synthesis via L-arginine/eNOS pathway, (2) transcriptional upregulation of VEGF-A and FGF-2 favouring angiogenesis, (3) modulation of the Egr-1 early transcription factor involved in fibroblast proliferation, (4) interaction with 5-HT2A and dopaminergic receptors in some behavioural models, (5) stabilisation of endothelial function via eNOS modulation and reduction of oxidative stress (8-OH-dG, MDA)
However, NDI1 expression normalized glucose tolerance, insulin release and lipid clearance comparable to that of control mice (Fig
Yes, protect from direct light
Higher doses are associated with potential side effects such as severe abdominal pain, stomach problems, nausea, vomiting, diarrhea, and constipation
Understanding what to avoid when taking glutathione IV is key to maximizing the benefits of the therapy and ensuring optimal results